Viking Therapeutics Email Formats
Pharmaceutical Manufacturing • 
12340 El Camino Real, San Diego, United States • 21-50 Employees
Viking Therapeutics Email Formats
Viking Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@vikingtherapeutics.com), used 70.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@vikingtherapeutics.com | 70.5% |
{first name}{last name} | johndoe@vikingtherapeutics.com | 18.2% |
{last name}{last name} | doedoe@vikingtherapeutics.com | 6.8% |
{f2}{last name} | {f2}doe@vikingtherapeutics.com | 4.5% |
Key Contacts at Viking Therapeutics
Carol Hall
Human Resources Director
Toni-Joy Motomura Pharmd
Director Of Clinical Supply Chain
Sean Weigle
Director Of Finance And Controller
Maureen Mcgonegal Barnes
Executive Director, Pharmaceutical Development
Laura Browning
Senior Director Quality And Compliance
Johnny Pham
Associate Director, Pharmaceutical Development
Adedayo Kukoyi
Associate Director, Quality Engineering: Drug-Device Combination Pre-Filled Syringe, Autoinjector
Kader Yagiz
Senior Director, Pharmacology
Shengxia Summer
Director, Statistical Programming And Data Management
Tavette Neskorik
Sr Director, Clinical Operations
Company overview
| Headquarters | 12340 El Camino Real, San Diego, California 92130, US |
| Phone number | +18587044660 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2012 |
| Employees | 21-50 |
| Socials |
About Viking Therapeutics
Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and endocrine disorders. Our most advanced candidate is a non-steroidal selective androgen receptor modulator (SARM) currently in Phase 2 trial for the treatment recovery from hip fracture surgery. Our thyroid receptor beta (TRb) agonist platform, also in Phase 2, is being developed for lipid disorders such as hypercholesterolemia and fatty liver diseases such as non-alcoholic steatohepatitis (NASH) as well as for rare diseases of glycogen storage disease (GSD 1a) and X-linked adrenoleukodystrophy, or X-ALD. See more at http://www.vikingtherapeutics.com
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Viking Therapeutics has 22 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Viking Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Viking Therapeutics Tech Stack
Discover the technologies and tools that power Viking Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
Security
JavaScript libraries
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
Spain
Australia
NetherlandsFrequently asked questions
4.8
40,000 users
